LOGIN (VIA WILEY ONLINE LIBRARY)
Question:In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?
EXCERPT of full Clinical Answer
This Cochrane Clinical Answer evaluates angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression of diabetic kidney disease.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
Are you a COCHRANE CLINICAL ANSWERS subscriber?
SUBSCRIBE NOW to read the full answer
A subscription to THE COCHRANE LIBRARY is required.
Sign in:
Other login options:
Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.
Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.
Browse Clinical Answers
- Blood disorders
- Cancer
- Child health
- Complementary & alternative medicine
- Dentistry & oral health
- Ear, nose & throat
- Endocrine & metabolic
- Gastroenterology
- Gynecology
- Health & safety at work
- Heart & circulation
- Infectious disease
- Kidney disease
- Lungs & airways
- Mental health
- Neonatal care
- Neurology
- Orthopedics & trauma
- Pain & anesthesia
- Pregnancy & childbirth
- Rheumatology
- Skin
- Wounds